GlassScriptPhysician profile
Arlynna Hendrix
NPI 1841828464
$4,400.88
in general payments reported to CMS, 2019-2025
35 companies · $1,667 in 2025
The $1,667 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $121 · 2023: $932 · 2024: $1,682 · 2025: $1,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,260 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,259.79 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $720.67 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $628.27 | 2023-2025 | |
| Novo Nordisk INC | $551.81 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $260.34 | 2023-2025 | Zepbound, Mounjaro, Emgality |
| Glaxosmithkline, LLC. | $253.37 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Otsuka America Pharmaceutical, INC. | $160.35 | 2023-2025 | Rexulti |
| Amgen INC. | $152.96 | 2023-2025 | Repatha, Otezla, Evenity |
| Merck Sharp & Dohme LLC | $136.38 | 2023-2025 | Verquvo, Belsomra, Gardasil 9 |
| Dexcom, INC. | $111.67 | 2022-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $106.82 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $106.07 | 2023-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $105.87 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $103.61 | 2022-2024 | Xarelto |
| Verona Pharma, INC. | $98.51 | 2025 | Ohtuvayre |
| Astellas Pharma US INC | $97.25 | 2023-2025 | Veozah, Myrbetriq |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlynna Hendrix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.